 |
| |||||
|
| ||||||
|
||||||
|
Products »
Business Development With a keen interest in new opportunities combined with a solid financial position, Zila seeks to further expand its oral disease detection and treatment portfolio into new markets. Zila has already completed several company, product, and technology acquisitions, and expects to continue its robust business development program as an important element of its overall growth strategy. We are committed to continued growth and are interested in learning about prospective opportunities in the specialty pharmaceutical market. Please direct your inquiries regarding business or product collaboration opportunities to: By Facsimile: 602-234-2318 By Regular Mail:
|
||||||
Zila and TOLMAR are now one company! Get the exciting details here. | ||||||
 | ||||||
| ||||||
